Condition: Asthma
Interventions: Drug: Montelukast 5 mg chewable tablets; Drug: Montelukast 5 mg chewable tablets
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed – verified May 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days